Research Archive — Page 121 of 133
-
September 26, 2016
Study shows excess dietary zinc worsens C. diff infection
Too much dietary zinc increases susceptibility to infection by Clostridium difficile — “C. diff” — the most common cause of hospital-acquired infections. -
September 8, 2016
Investigators create ‘Trojan Horse’ to fight Ebola
A multi-center research team including scientists from the Vanderbilt Vaccine Center has come up with a clever “Trojan Horse” strategy for thwarting the highly lethal Ebola virus. -
August 15, 2016
In search of new asthma therapies
A peptide molecule relaxes airway smooth muscle and may be a potential therapeutic for asthma that has become resistant to standard therapies. -
August 12, 2016
New culprit in nerve degeneration
Vanderbilt researchers have discovered that regulation of cell volume plays a role in nerve degeneration and peripheral neuropathies. -
August 11, 2016
Research team takes aim at Ebola virus ‘decoy protein’
Using an antibody generated at Vanderbilt University Medical Center that neutralizes the Ebola virus, researchers at the Scripps Research Institute in La Jolla, California, have determined the structure of a “decoy” protein that may enable the virus to evade detection by the immune system. -
August 11, 2016
Study explores low oxygen’s impact on antibody quality
Hypoxia (lack of enough oxygen) is bad for the body as a whole, but in the neighborhood where infection-fighting antibodies arise, may be important for keeping proper order. -
August 11, 2016
Study reveals neurotransmitter glutamate’s molecular structure
Terunaga Nakagawa, with colleagues from Japan and Oxford University in England, has discovered the bridgelike molecular structure of a mysterious glutamate receptor.